Georgia Picht

Mr. Picht joined Harpoon in January 2017 with more than 25 years of industry experience in strategic finance, operations, investor relations, business planning and oversight. Prior to Harpoon, he served as chief financial officer for Pearl Therapeutics, a respiratory disease company that was sold to AstraZeneca in a $1.15 billion transaction. At Pearl, Mr. Picht was responsible for finance, administration and information technology. Previously, he served as head of R&D finance at Nektar Therapeutics, and conducted finance and market analytics at Syntex. Mr. Picht received his BA from the University of Notre Dame and his MBA from San Jose State University.

Georgia Picht is the CFO at Harpoon Therapeutics. With a background in Biotechnology, Georgia Picht has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.